Subscribe

Anteris Technologies Global Corp. (AVR)

USD8.72 -0.23 (-2.57%)
AU NASDAQ Healthcare Medical - Devices
Address Toowong Tower 4066
Toowong, QLD, AU
CEO Wayne Geoffrey Paterson
Website anteristech.com
IPO 2024-12-13
CIK 2011514 ISIN US03675P1021

Explore sections of this company profile

Description

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD8.72 -0.23 (-2.57%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
0.73
Float Shares
25.14M
Free Float %
68.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+2.92% +3.88% +8.06% +17.34% +76.78% +34.27% +47.25% +19.64% +19.64% +19.64% +19.64%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (1 ratings, all time) Buy
Price Targets & DCF
Current price
8.72
Low 15.00 +72.0%
Consensus 15.00 +72.0%
Median 15.00 +72.0%
High 15.00 +72.0%
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 3 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month — —
Last Quarter — —
Last Year 1
15.00
+72.0%
All Time 2
12.00
+37.6%
Quality scores
Altman Z-Score
7.53
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Medical - Devices: +11.2%
    -29.2% Q1'26: -11.2% (vs Q1'25)
  • ✗
    EPS growth Medical - Devices: +28.5%
    -6.1% Q1'26: +69.9% (vs Q1'25)
  • ✗
    FCF margin FCF growth · Medical - Devices: +30.9%
    -4,598.1% Q1'26: -5,805.7% (vs Q1'25)
  • ✗
    EBIT margin Medical - Devices: +6.2%
    -4,921.7% Q1'26: +0.0% (vs Q1'25)
  • ✓
    ROIC Medical - Devices: +3.3%
    — Q1'26: +0.0% (vs Q1'25)
  • ✗
    Share dilution Medical - Devices: 0.0%
    +16.4% Q1'26: -100.0% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    -0.02× Q1'26: 0.54× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.59) × ERP
WACC = 99% × Ke + 1% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Current price: 8.72
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
3 Rev. Ana.
2 EPS Ana. 		Dec 2027
3 Rev. Ana.
1 EPS Ana. 		Dec 2028
3 Rev. Ana.
1 EPS Ana. 		Dec 2029
2 Rev. Ana.
1 EPS Ana. 		Dec 2030
1 Rev. Ana.
1 EPS Ana.
Revenue
2.73M
est: 4.57M (-40.2%)
2.70M
est: 2.85M (-5.2%)
1.91M
est: 1.80M (+6.3%)
7.96M
1.92M – 14.18M
+342.5% YoY
13.82M
6.97M – 24.80M
+73.5% YoY
16.94M
6.91M – 30.31M
+22.6% YoY
168.32M
68.69M – 301.16M
+893.6% YoY
321.35M
131.14M – 574.98M
+90.9% YoY
EBITDA
-45.54M
est: -4.57M (-895.6%)
-76.87M
est: -2.85M (-2,597.0%)
-92.49M
est: -1.80M (-5,038.4%)
-7.96M
-14.18M – -1.92M
-342.5% YoY
-13.82M
-24.80M – -6.97M
-73.5% YoY
-16.94M
-30.31M – -6.91M
-22.6% YoY
-168.32M
-301.16M – -68.69M
-893.6% YoY
-321.35M
-574.98M – -131.14M
-90.9% YoY
EBIT
-46.70M
est: -4.57M (-920.9%)
-78.37M
est: -2.85M (-2,649.9%)
-94.15M
est: -1.80M (-5,130.7%)
-7.96M
-14.18M – -1.92M
-342.5% YoY
-13.82M
-24.80M – -6.97M
-73.5% YoY
-16.94M
-30.31M – -6.91M
-22.6% YoY
-168.32M
-301.16M – -68.69M
-893.6% YoY
-321.35M
-574.98M – -131.14M
-90.9% YoY
Net Income
-46.02M
est: -45.00M (-2.3%)
-76.29M
est: -81.81M (+6.7%)
-94.23M
est: -86.43M (-9.0%)
-36.00M
-49.16M – -22.83M
+58.3% YoY
-31.06M
-55.77M – -6.35M
+13.7% YoY
-25.54M
-45.87M – -5.22M
+17.8% YoY
-19.45M
-39.41M – -4.48M
+23.9% YoY
-15.44M
-31.29M – -3.56M
+20.6% YoY
SGA
17.05M
est: 11.93M (+42.9%)
—
est: 14.94M (-100.0%)
26.12M
est: 9.43M (+176.8%)
41.74M
10.06M – 74.32M
+342.5% YoY
72.44M
36.53M – 129.98M
+73.5% YoY
88.78M
36.23M – 158.85M
+22.6% YoY
882.17M
360.01M – 1.58B
+893.6% YoY
1.68B
687.34M – 3.01B
+90.9% YoY
EPS
-1.28
est: -2.22 (+42.4%)
-3.77
est: -2.97 (-26.8%)
-4.00
est: -2.26 (-76.7%)
-1.53
-2.09 – -0.97
+32.3% YoY
-1.17
-2.37 – -0.27
+23.8% YoY
-0.96
-1.95 – -0.22
+17.8% YoY
-0.83
-1.67 – -0.19
+14.1% YoY
-0.66
-1.33 – -0.15
+20.6% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-08 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-07 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-06 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-05 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-04 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-05-01 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-30 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-29 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-28 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-27 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-24 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-23 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-22 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-21 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-20 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-17 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5
2026-04-16 C 2/5 1/5 5/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-80.53M
OE per share TTM
-3.42
Owner's Yield
-52.47%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
117.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
18
Total invested
5.17M
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
18
-55 vs prev Q
New positions
8
Closed positions
63
Increased
16
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
# Investor ⇅ Shares / Δ ⇅ Mkt value / Δ ⇅ Own% / Δ ⇅ Weight% / Δ ⇅ Avg px / Perf. ⇅ Hold / Status ⇅
1 L1 CAPITAL PTY LTD 2.81M -4.0M (-58.9%) 14.03M -13.2M (-48.4%) 11.93% -17.077 pp 0.73% -0.986 pp USD4.47 +11.6% 5 qtrs —
2 NANTAHALA CAPITAL MANAGEMENT, LLC 2.53M +612.2K (+31.9%) 12.63M +4.0M (+46.3%) 10.73% +2.597 pp 0.42% +0.118 pp USD5.32 -6.2% 5 qtrs —
3 BLACKROCK, INC. 2.03M +139.6K (+7.4%) 10.11M +1.6M (+19.1%) 8.60% +0.592 pp 0.00% +0.000 pp USD4.14 +20.5% 4 qtrs —
4 SIO CAPITAL MANAGEMENT, LLC 1.87M +102.0K (+5.8%) 9.35M +1.4M (+17.3%) 7.95% +0.433 pp 1.47% -0.547 pp USD5.55 -10.1% 5 qtrs —
5 PERCEPTIVE ADVISORS LLC 1.68M -29.7K (-1.7%) 8.36M +687.5K (+9.0%) 7.11% -0.126 pp 0.15% -0.073 pp USD5.58 -10.6% 5 qtrs —
6 JPMORGAN CHASE & CO 1.41M -11.9K (-0.8%) 7.01M +635.5K (+10.0%) 5.96% -0.050 pp 0.00% +0.000 pp USD3.96 +26.0% 4 qtrs —
7 ENSIGN PEAK ADVISORS, INC 1.40M -7.7K (-0.5%) 6.99M +651.7K (+10.3%) 5.94% -0.033 pp 0.01% +0.002 pp USD5.04 -1.0% 5 qtrs —
8 ADAR1 CAPITAL MANAGEMENT, LLC 1.24M +1.0M (+526.9%) 6.18M +5.3M (+595.1%) 5.25% +4.416 pp 0.45% +0.371 pp USD4.97 +0.4% 5 qtrs —
9 RHENMAN & PARTNERS ASSET MANAGEMENT AB 1.24M -12.1K (-1.0%) 6.18M +552.3K (+9.8%) 5.25% -0.052 pp 0.58% -0.045 pp USD3.64 +37.1% 4 qtrs —
10 VANGUARD GROUP INC 841.3K +95.8K (+12.8%) 4.20M +843.3K (+25.1%) 3.57% +0.406 pp 0.00% +0.000 pp USD4.20 +18.8% 4 qtrs —
11 GEODE CAPITAL MANAGEMENT, LLC 796.1K +47.1K (+6.3%) 3.97M +602.2K (+17.9%) 3.38% +0.200 pp 0.00% +0.000 pp USD4.12 +21.1% 4 qtrs —
12 UBS GROUP AG 515.7K +294.7K (+133.3%) 2.57M +1.6M (+158.7%) 2.19% +1.250 pp 0.00% +0.000 pp USD4.45 +12.1% 4 qtrs —
13 EVERSEPT PARTNERS, LP 500.0K +— (+0.0%) 2.50M +245.0K (+10.9%) 2.12% +0.000 pp 0.13% -0.029 pp USD4.50 +10.9% 2 qtrs —
14 AFFINITY ASSET ADVISORS, LLC 486.7K +36.7K (+8.2%) 2.43M +403.6K (+19.9%) 2.06% +0.156 pp 0.14% -0.038 pp USD4.99 +0.0% 5 qtrs —
15 STATE STREET CORP 357.8K +45.1K (+14.4%) 1.79M +378.2K (+26.9%) 1.52% +0.191 pp 0.00% +0.000 pp USD4.15 +20.2% 4 qtrs —
16 NORTHERN TRUST CORP 254.6K -475.0 (-0.2%) 1.27M +122.6K (+10.7%) 1.08% -0.002 pp 0.00% +0.000 pp USD4.07 +22.6% 4 qtrs —
17 CITIGROUP INC 181.3K +179.9K (+12,481.4%) 904.7K +898.2K (+13,850.3%) 0.77% +0.763 pp 0.00% +0.000 pp USD4.98 +0.2% 4 qtrs —
18 SYMMETRY INVESTMENTS LP 158.3K -3.5K (-2.1%) 790.1K +62.0K (+8.5%) 0.67% -0.015 pp 0.07% +0.034 pp USD5.16 -3.3% 5 qtrs —
19 GOLDMAN SACHS GROUP INC 152.6K -98.5K (-39.2%) 761.3K -368.7K (-32.6%) 0.65% -0.418 pp 0.00% +0.000 pp USD4.48 +11.4% 5 qtrs —
20 BARCLAYS PLC 148.1K +4.3K (+3.0%) 739.2K +91.9K (+14.2%) 0.63% +0.018 pp 0.00% +0.000 pp USD3.76 +32.7% 4 qtrs —
21 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 100.9K +— (+0.0%) 503.5K +49.4K (+10.9%) 0.43% +0.000 pp 0.00% +0.000 pp USD4.07 +22.6% 4 qtrs —
22 BEARING POINT CAPITAL, LLC 95.6K +4.6K (+5.0%) 476.8K +67.3K (+16.4%) 0.41% +0.019 pp 0.07% +0.004 pp USD4.00 +24.8% 3 qtrs —
23 MILLENNIUM MANAGEMENT LLC 85.6K +15.3K (+21.7%) 427.4K +110.7K (+34.9%) 0.36% +0.065 pp 0.00% +0.000 pp USD5.27 -5.3% 5 qtrs —
24 MORGAN STANLEY 80.4K +6.8K (+9.2%) 401.1K +69.8K (+21.1%) 0.34% +0.029 pp 0.00% +0.000 pp USD3.82 +30.6% 4 qtrs —
25 OASIS MANAGEMENT CO LTD. 76.0K -36.3K (-32.3%) 379.0K -125.9K (-24.9%) 0.32% -0.154 pp 0.02% -0.024 pp USD5.58 -10.6% 5 qtrs —
26 BANK OF NEW YORK MELLON CORP 75.4K +643.0 (+0.9%) 376.2K +39.8K (+11.8%) 0.32% +0.003 pp 0.00% +0.000 pp USD4.12 +21.1% 4 qtrs —
27 BANK OF AMERICA CORP /DE/ 61.1K +50.4K (+474.4%) 304.7K +256.9K (+537.0%) 0.26% +0.214 pp 0.00% +0.000 pp USD4.80 +4.0% 4 qtrs —
28 LOS ANGELES CAPITAL MANAGEMENT LLC 64.9K +64.9K (+100.0%) 279.7K +279.7K (+100.0%) 0.28% +0.275 pp 0.00% +0.001 pp USD4.99 +0.0% 1 qtrs NEW
29 NUVEEN, LLC 42.7K +— (+0.0%) 213.0K +20.9K (+10.9%) 0.18% +0.000 pp 0.00% +0.000 pp USD3.75 +33.1% 4 qtrs —
30 FMR LLC 39.6K +3.0K (+8.3%) 197.8K +33.1K (+20.1%) 0.17% +0.013 pp 0.00% +0.000 pp USD4.01 +24.4% 5 qtrs —
31 RHUMBLINE ADVISERS 37.6K +4.4K (+13.4%) 187.8K +38.4K (+25.7%) 0.16% +0.019 pp 0.00% +0.000 pp USD4.03 +23.8% 4 qtrs —
32 WELLS FARGO & COMPANY/MN 37.2K +16.3K (+78.1%) 185.4K +91.5K (+97.5%) 0.16% +0.069 pp 0.00% +0.000 pp USD4.47 +11.6% 4 qtrs —
33 INVESCO LTD. 36.6K +688.0 (+1.9%) 182.7K +21.0K (+13.0%) 0.16% +0.003 pp 0.00% +0.000 pp USD3.69 +35.2% 4 qtrs —
34 BRIDGEWAY CAPITAL MANAGEMENT, LLC 35.0K +35.0K (+100.0%) 174.7K +174.7K (+100.0%) 0.15% +0.149 pp 0.00% +0.004 pp USD4.99 +0.0% 1 qtrs NEW
35 MACQUARIE GROUP LTD 33.7K +33.4K (+12,369.6%) 168.0K +166.8K (+13,727.4%) 0.14% +0.142 pp 0.00% +0.001 pp USD4.98 +0.2% 4 qtrs —
36 WALLEYE CAPITAL LLC 29.5K +29.5K (+100.0%) 147.4K +147.4K (+100.0%) 0.13% +0.125 pp 0.00% +0.001 pp USD4.99 +0.0% 1 qtrs NEW
37 DEUTSCHE BANK AG\ 28.9K +2.2K (+8.1%) 144.0K +23.9K (+19.9%) 0.12% +0.009 pp 0.00% +0.000 pp USD3.80 +31.3% 4 qtrs —
38 WELLINGTON SHIELDS & CO., LLC 27.1K -1.0K (-3.6%) 135.5K +8.7K (+6.9%) 0.12% -0.004 pp 0.03% +0.000 pp USD3.66 +36.3% 4 qtrs —
39 PRIVATE ADVISOR GROUP, LLC 26.1K +26.1K (+100.0%) 130.2K +130.2K (+100.0%) 0.11% +0.111 pp 0.00% +0.001 pp USD4.99 +0.0% 1 qtrs NEW
40 PERSISTENT ASSET PARTNERS LTD 23.3K +— (+0.0%) 116.4K +11.4K (+10.9%) 0.10% +0.000 pp 0.05% -0.020 pp USD3.64 +37.1% 4 qtrs —
41 PRICE T ROWE ASSOCIATES INC /MD/ 22.9K +10.1K (+78.7%) 115.0K +57.0K (+98.3%) 0.10% +0.043 pp 0.00% +0.000 pp USD4.72 +5.7% 2 qtrs —
42 AQR CAPITAL MANAGEMENT LLC 22.0K +435.0 (+2.0%) 109.6K +12.7K (+13.1%) 0.09% +0.002 pp 0.00% +0.000 pp USD3.81 +31.0% 3 qtrs —
43 LPL FINANCIAL LLC 17.3K -1.4K (-7.5%) 86.3K +2.2K (+2.6%) 0.07% -0.006 pp 0.00% +0.000 pp USD4.50 +10.9% 2 qtrs —
44 MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 15.8K +16.0 (+0.1%) 78.8K +7.8K (+11.0%) 0.07% +0.000 pp 0.00% +0.000 pp USD3.89 +28.3% 4 qtrs —
45 INTECH INVESTMENT MANAGEMENT LLC 13.5K +13.5K (+100.0%) 67.2K +67.2K (+100.0%) 0.06% +0.057 pp 0.00% +0.001 pp USD4.99 +0.0% 3 qtrs —
46 DUNCAN WILLIAMS ASSET MANAGEMENT, LLC 10.9K +10.9K (+100.0%) 60.5K +60.5K (+100.0%) 0.05% +0.046 pp 0.02% +0.015 pp USD4.99 +0.0% 1 qtrs NEW
47 CETERA INVESTMENT ADVISERS 10.1K +— (+0.0%) 50.2K +4.9K (+10.9%) 0.04% +0.000 pp 0.00% +0.000 pp USD4.50 +10.9% 2 qtrs —
48 BNP PARIBAS ARBITRAGE, SNC 8.3K -1.1K (-12.0%) 41.6K -1.0K (-2.4%) 0.04% -0.005 pp 0.00% +0.000 pp USD4.03 +23.8% 4 qtrs —
49 POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 7.6K +— (+0.0%) 37.9K +3.7K (+10.9%) 0.03% +0.000 pp 0.00% +0.000 pp USD4.07 +22.6% 4 qtrs —
50 METLIFE INVESTMENT MANAGEMENT, LLC 6.6K -15.0K (-69.3%) 33.1K -64.3K (-66.0%) 0.03% -0.064 pp 0.00% 0.000 pp USD4.50 +10.9% 2 qtrs —
51 RUSSELL INVESTMENTS GROUP, LTD. 6.5K +— (+0.0%) 32.6K +3.2K (+10.9%) 0.03% +0.000 pp 0.00% +0.000 pp USD4.10 +21.7% 3 qtrs —
52 NEW YORK STATE COMMON RETIREMENT FUND 4.9K +— (+0.0%) 24.5K +2.4K (+10.9%) 0.02% +0.000 pp 0.00% +0.000 pp USD3.64 +37.1% 4 qtrs —
53 BARTLETT & CO. WEALTH MANAGEMENT LLC 4.7K +3.2K (+213.3%) 23.5K +16.7K (+247.5%) 0.02% +0.014 pp 0.00% +0.000 pp USD4.74 +5.3% 4 qtrs —
54 LEGAL & GENERAL GROUP PLC 3.4K -183.0 (-5.0%) 17.2K +829.0 (+5.1%) 0.01% -0.001 pp 0.00% +0.000 pp USD3.97 +25.7% 4 qtrs —
55 ROYAL BANK OF CANADA 3.1K -24.1K (-88.6%) 15.0K -108.0K (-87.8%) 0.01% -0.102 pp 0.00% +0.000 pp USD4.42 +12.9% 4 qtrs —
56 TOWER RESEARCH CAPITAL LLC (TRC) 2.5K -811.0 (-24.8%) 12.3K -2.4K (-16.6%) 0.01% -0.003 pp 0.00% 0.000 pp USD3.78 +32.0% 4 qtrs —
57 ADVISOR GROUP HOLDINGS, INC. 2.2K -93.0 (-4.1%) 11.0K +967.0 (+9.7%) 0.01% 0.000 pp 0.00% +0.000 pp USD3.67 +36.0% 4 qtrs —
58 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 2.1K -5.1K (-71.1%) 10.4K -22.1K (-68.0%) 0.01% -0.022 pp 0.00% +0.000 pp USD4.39 +13.7% 4 qtrs —
59 AMERITAS INVESTMENT PARTNERS, INC. 1.5K +— (+0.0%) 7.6K +745.0 (+10.9%) 0.01% +0.000 pp 0.00% +0.000 pp USD3.64 +37.1% 4 qtrs —
60 GAMMA INVESTING LLC 1.3K +1.3K (+100.0%) 6.7K +6.7K (+100.0%) 0.01% +0.006 pp 0.00% +0.000 pp USD4.99 +0.0% 1 qtrs NEW
61 AMALGAMATED BANK 1.1K +549.0 (+106.0%) 5.0K +3.0K (+150.0%) 0.00% +0.002 pp 0.00% +0.000 pp USD4.33 +15.2% 4 qtrs —
62 CWM, LLC 854.00 -21.0 (-2.4%) 4.0K +— (+0.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD3.79 +31.7% 3 qtrs —
63 — 503.00 +503.0 (+100.0%) 2.5K +2.5K (+100.0%) 0.00% +0.002 pp 0.00% +0.001 pp USD4.99 +0.0% 1 qtrs NEW
64 NISA INVESTMENT ADVISORS, LLC 288.00 +— (+0.0%) 1.4K +141.0 (+10.9%) 0.00% +0.000 pp 0.00% +0.000 pp USD3.79 +31.7% 3 qtrs —
65 STERLING CAPITAL MANAGEMENT LLC 221.00 +139.0 (+169.5%) 1.1K +734.0 (+198.9%) 0.00% +0.001 pp 0.00% +0.000 pp USD4.60 +8.5% 4 qtrs —
66 EVERSOURCE WEALTH ADVISORS, LLC 40.00 +9.0 (+29.0%) 200.00 +60.0 (+42.9%) 0.00% +0.000 pp 0.00% +0.000 pp USD4.03 +23.8% 3 qtrs —
67 PNC FINANCIAL SERVICES GROUP, INC. 29.00 +24.0 (+480.0%) 145.00 +122.0 (+530.4%) 0.00% +0.000 pp 0.00% +0.000 pp USD4.86 +2.7% 2 qtrs —
68 SUNBELT SECURITIES, INC. 22.00 +2.0 (+10.0%) 110.00 +20.0 (+22.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD4.50 +10.9% 2 qtrs —
69 TRUE WEALTH DESIGN, LLC 4.00 +2.0 (+100.0%) 20.00 +11.0 (+122.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD4.00 +24.8% 3 qtrs —
70 SRS CAPITAL ADVISORS, INC. 4.00 -637.0 (-99.4%) 20.00 -2.9K (-99.3%) 0.00% -0.003 pp 0.00% +0.000 pp USD4.25 +17.4% 2 qtrs —
71 ALLWORTH FINANCIAL LP 2.00 +1.0 (+100.0%) 10.00 +5.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD3.50 +42.6% 3 qtrs —
72 IFP ADVISORS, INC 1.00 +— (+0.0%) 5.00 +1.0 (+25.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD4.00 +24.8% 2 qtrs —
73 BALYASNY ASSET MANAGEMENT L.P. — -11.5K (-100.0%) — -51.8K (-100.0%) 0.00% -0.049 pp 0.00% 0.000 pp USD— 2 qtrs SOLD
74 ALYESKA INVESTMENT GROUP, L.P. — -550.0K (-100.0%) — -2.5M (-100.0%) 0.00% -2.333 pp 0.00% -0.008 pp USD— 5 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 46 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 State Street SPDR S&P Health Care Equipment ETF XHE 0.70% 1.06M 0.35%
2 Invesco Dorsey Wright SmallCap Momentum ETF DWAS 0.38% 1.79M 0.60%
3 iShares Micro-Cap ETF IWC 0.18% 2.67M 0.60%
4 Federated Hermes MDT Small Cap Core ETF FSCC 0.18% 292.4K 0.51%
5 Fidelity Sustainable High Yield ETF FSYD 0.05% 73.3K 0.55%
6 iShares Russell 2000 Value ETF IWN 0.05% 7.29M 0.24%
7 Vanguard Russell 2000 Growth ETF VTWG 0.04% 634.2K 0.06%
8 iShares Russell 2000 BuyWrite ETF IWMW 0.03% 14.6K 0.39%
9 iShares Russell 2000 ETF IWM 0.03% 21.31M 0.19%
10 iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO 0.03% 139.1K 0.36%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
5.08M
Shares disposed
—
Cash buys
1.00
Cash sales
—
Net activity
+5,078,740
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-04 McDonnell Matthew Officer A-Award A Restricted Stock Units 78,740 0.00 — 78,740 D ↗
2026-01-22 Medtronic plc 10% Owner — — Common Stock 0 0.00 — 15,652,173 I ↗
2026-01-22 L1 Capital Pty Ltd 10% Owner P-Purchase A Common Stock 5,000,000 5.75 28.75M 13,219,814 I ↗
2025-12-16 St Denis David Director / Officer F-InKind D Common Stock 65,584 4.95 324.6K 101,082 D ↗
2025-12-16 Seaberg John D Director M-Exempt A Common Stock 27,777 0.00 — 43,635 D ↗
2025-12-16 Paterson Wayne Director / Officer M-Exempt A Common Stock 333,333 0.00 — 345,940 I ↗
2025-12-16 McDonnell Matthew Officer M-Exempt A Common Stock 27,777 0.00 — 27,777 I ↗
2025-12-03 Seaberg John D Director A-Award A Restricted Stock Units 83,333 0.00 — 83,333 D ↗
2025-12-03 Roberts David B Director A-Award A Restricted Stock Units 52,742 0.00 — 52,742 D ↗
2025-12-03 Paterson Wayne Director / Officer A-Award A Restricted Stock Units 1,000,000 0.00 — 1,000,000 D ↗
2025-12-03 Moss Gregory S. Director A-Award A Restricted Stock Units 52,742 0.00 — 52,742 D ↗
2025-12-03 Denaro Stephen Director A-Award A Restricted Stock Units 41,666 0.00 — 41,666 D ↗
2025-10-28 L1 Capital Pty Ltd 10% Owner P-Purchase A CHESS Depository Interests 1,333,334 0.00 — 1,333,334 I ↗
2025-06-07 Roberts David B — — — — 0 0.00 — 0 — ↗
2025-06-07 Moss Gregory S. — — — — 0 0.00 — 0 — ↗
2008-09-24 BUTZ THEODORE H Director — D Restricted stock units 19 0.00 — 0 — ↗
2008-02-28 SABHERWAL AJAY Officer A-Award A Option to purchase common stock 80,000 7.05 564.0K 545,008 — ↗
2007-08-13 SABHERWAL AJAY Officer M-Exempt D Option to purchase 54,168 4.35 235.6K 465,008 — ↗
2007-02-28 SABHERWAL AJAY Officer M-Exempt A Common stock 32,455 4.35 141.2K 32,455 — ↗
2007-02-27 SABHERWAL AJAY Officer S-Sale D Common stock 1,865 16.33 30.5K 0 — ↗
2006-07-05 SABHERWAL AJAY Officer M-Exempt D Option to Purchase Common Stock 19,848 4.35 86.3K 413,496 — ↗
2006-06-28 Sneed James R Officer — D Option to Purchase Common Stock 79,080 0.23 18.2K 0 — ↗
2006-06-28 SABHERWAL AJAY Officer — D Option to Purchase Common Stock 433,344 4.35 1.89M 0 — ↗
2004-10-04 PHILDIUS PETER P Director / Officer A-Award A Stock Options 90,720 0.07 6.4K 2,600,880 — ↗

Executive team

Top executives
EBIT / Employee
-6.9K
Shares Outstanding
36.79M

Executive compensation

Executive compensation (annual)
# Year ⇅ Executive ⇅ Salary ⇅ Bonus Stock award ⇅ Option award Incentive Other Total ⇅ % Stock-
based ⇅		 Filing
1 2024 David St Denis President and Former Chief Operating Officer 450.0K 50.0K 3.00M — 380.0K 34.6K 3.91M 76.64% ↗
2 2024 Wayne Paterson Vice Chairman and Chief Executive Officer 696.4K 125.0K — 1.46M 725.0K 35.5K 3.04M 48.02% ↗
3 2024 Matthew McDonnell Chief Financial Officer 267.4K 50.0K 500.0K — 158.8K 24.5K 1.00M 49.97% ↗
4 2023 Wayne Paterson Vice Chairman and Chief Executive Officer 676.4K 200.0K — 5.51M 393.6K 35.2K 6.82M 80.85% ↗
5 2023 David St Denis President and Former Chief Operating Officer 416.8K 20.0K — 3.97M 249.5K 35.0K 4.69M 84.63% ↗
6 2023 Matthew McDonnell Chief Financial Officer 242.3K — — 1.27M 105.3K 20.1K 1.64M 77.53% ↗
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-11-10 DEF 14A ↗
2025-10-30 PRE 14A ↗
2025-09-19 DEFA14A ↗
2025-09-11 DEFA14A ↗
2025-09-04 DEFA14A ↗
2025-08-18 DEF 14A ↗
2025-08-08 PRE 14A ↗

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-04 SC 13G/A ↗
2026-04-30 424B3 ↗
2026-04-29 8-K ↗
2026-04-27 SC 13G ↗
2026-04-27 424B3 ↗
2026-04-23 8-K ↗
2026-03-18 424B3 ↗
2026-03-13 EFFECT ↗
2026-03-10 POS AM ↗
2026-03-06 4 ↗

Executive team

NameTitleCompensationGender
Wayne Geoffrey Paterson Vice Chairman & Chief Executive Officer 2M male
David Denis President & Director 981.9K male
Matthew McDonnell Chief Financial Officer 457.4K male
Chris Meduri Chief Medical Officer & Member of Medical Advisory Board — —
ESG Rating
B
MEDICAL - DEVICES
Rank: 69 out of 152
2025
E (Environmental)
65.0 / 62.5
Company / Sector avg.
S (Social)
65.5 / 68.9
Company / Sector avg.
G (Governance)
61.7 / 64.8
Company / Sector avg.
ESG Total
64.1 / 65.4
Company / Sector avg.
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Devices